Responses
Regular and young investigator award abstracts
Clinical trials in progress
334 Phase II study evaluating a chemokine-modulatory (CKM) regimen in patients with colorectal cancer (CRC) metastatic to the liver
Compose a Response to This Article
Other responses
No responses have been published for this article.